BRCA1 rs121918403: Understanding Hereditary Cancer Risk Variants
The rs121918403 variant is a specific genetic change located within the BRCA1 gene. It is associated with an increased risk of hereditary breast and ovarian cancer syndrome, a condition that predisposes individuals to certain types of cancer.
What each genotype means
Typical BRCA1 sequence
This genotype represents the most common sequence found at this position in the BRCA1 gene. It is considered the reference or wild-type sequence, and individuals with this genotype do not carry the specific variant associated with the increased risk described in the catalog.
This is the most common genotype observed across all global populations.
Heterozygous carrier status
This genotype indicates that one copy of the BRCA1 gene contains the variant, while the other copy is the common sequence. Research classifies this specific variant as benign, meaning it is not expected to contribute to hereditary breast and ovarian cancer syndrome. You should discuss any personal or family history of cancer with a genetic counselor or healthcare provider to understand your overall risk profile.
This genotype is rare in the general population.
Homozygous variant status
This genotype indicates that both copies of the BRCA1 gene carry this variant. Current clinical evidence classifies this variant as benign, suggesting it does not increase the risk of hereditary breast and ovarian cancer syndrome. As with any genetic finding, this should be interpreted in the context of your personal and family medical history by a qualified clinician.
This genotype is extremely rare in the general population.
What is the rs121918403 Variant?
The rs121918403 variant is a single nucleotide polymorphism (SNP) found within the BRCA1 gene, which is located on chromosome 17. In genetics, a SNP represents a variation at a single position in the DNA sequence. This specific variant is categorized as a trait-associated marker in genetic databases. Because it resides within the BRCA1 gene, researchers study it to understand how it might influence the gene's normal function. While many variants in the human genome are benign, those located in critical tumor suppressor genes like BRCA1 are subject to intense scientific scrutiny to determine if they disrupt the protein-coding instructions or regulatory mechanisms of the gene. Understanding the precise location and nature of this variant helps scientists map its potential impact on cellular health and disease susceptibility.
The Role of the BRCA1 Gene
The BRCA1 gene provides the essential instructions for creating a protein that acts as a tumor suppressor. Tumor suppressor proteins are vital for maintaining genomic stability; they function primarily by repairing damaged DNA within cells. When DNA damage occurs—whether from environmental factors or natural cellular processes—the BRCA1 protein helps orchestrate the repair process to ensure that the genetic code remains intact. If the BRCA1 gene contains a pathogenic variant that prevents it from functioning correctly, the cell may struggle to repair its DNA. This accumulation of unrepaired genetic damage can lead to uncontrolled cell growth, which is a hallmark of cancer development. Consequently, individuals who inherit certain harmful variants in this gene have a higher statistical likelihood of developing breast, ovarian, and other related cancers compared to the general population.
Research and Evidence Strength
The association between rs121918403 and hereditary breast and ovarian cancer syndrome is currently classified as having moderate evidence. Scientific research into this variant involves analyzing large cohorts of individuals to determine if the presence of the variant correlates with a higher incidence of cancer. While the BRCA1 gene is well-established as a high-penetrance gene, not every variant within it carries the same level of risk. Researchers use genome-wide association studies and clinical data to distinguish between variants that are clearly pathogenic and those that may have a more subtle or uncertain effect. Because the evidence for this specific variant is considered moderate, it remains a subject of ongoing investigation. Scientists continue to collect data to better define the exact risk profile associated with this variant, as clinical understanding often evolves as more genomic data becomes available.
Population Frequency and Clinical Context
The rs121918403 variant is considered rare in the general population. In genetics, rarity often means that the variant is not found in a large percentage of the global population, which can make it more challenging to study compared to common variants. Because it is rare, the statistical power to draw definitive conclusions about its impact can be limited, necessitating large-scale collaborative studies. It is important to note that having a rare variant does not automatically equate to a diagnosis of cancer. Genetic risk is complex and often involves the interplay of multiple genes, environmental factors, and lifestyle choices. If you have questions about your genetic results or family history, it is essential to discuss them with a qualified healthcare provider or a genetic counselor who can provide context based on your personal medical history.
Navigating Genetic Information
Information about genetic variants like rs121918403 is intended for educational purposes and should not be used to make personal medical decisions. Genetic testing results can be complex, and the presence of a variant does not necessarily mean that an individual will develop a specific condition. Conversely, the absence of a known variant does not guarantee that an individual is free from risk. If you are concerned about your hereditary cancer risk, the most appropriate step is to consult with a clinician or a certified genetic counselor. They can help interpret your results, assess your family history, and discuss whether further screening or preventive measures are appropriate for your specific situation. Never use genetic data to self-diagnose or alter medical treatments without professional guidance.
How common is this variant?
The rs121918403 variant is documented as rare across global populations, meaning it is found in only a very small fraction of individuals.
Frequently asked questions
Does having the rs121918403 variant mean I will get cancer?
No, having a genetic variant does not mean you will definitely develop cancer. Genetic risk is only one factor, and many people with variants never develop the associated conditions.
What should I do if I find this variant in my genetic report?
You should share your report with a healthcare professional or a genetic counselor. They can help you understand what the result means in the context of your personal and family health history.
Is BRCA1 testing recommended for everyone?
Genetic testing for BRCA1 is typically recommended for individuals with a strong family history of breast or ovarian cancer. It is not a routine test for the general population.
How does a variant in BRCA1 increase cancer risk?
Variants in BRCA1 can impair the gene's ability to produce a protein that repairs damaged DNA. When DNA repair is compromised, cells are more likely to accumulate mutations that can lead to cancer.
Sources & further reading
Educational information only, last refreshed 9/30/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs121918403?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in BRCA1
This rare variant has been recently annotated in clinical databases as a potential contributor to hereditary breast and ovarian cancer risk.
Variant identified in polygenic risk scores for breast cancer susceptibility.
A very rare variant identified in recent genomic studies, currently being investigated for potential associations with reproductive phenotypes.
This variant is a rare genetic alteration in the BRCA1 gene, which is critical for DNA repair and associated with hereditary breast and ovarian cancer syndromes impacting reproductive health.
A rare variant located in the BRCA1 gene, relevant to reproductive genetic counseling and the assessment of hereditary cancer risk.
This BRCA1 variant (p.Pro871Leu) is a common polymorphism often evaluated in breast cancer risk studies, though it is generally considered to have no clinical significance for hereditary breast and ovarian cancer syndrome.